| Structure | Chemical Name | CAS | MF |
|
IGFBP-6, ANTI-HUMAN
|
|
|
|
|
IGFBP-1
|
|
|
|
|
IGF BP-1 (PP14) Elisa(Standard Range: 0 - 50 ng/ml)
|
|
|
|
|
IGFBP-1/IGF-I Complex
|
|
|
|
|
IGFBP-1 (12 x 8 tests)
|
|
|
|
|
IGFBP-1(Standard Range: 1 - 180 μg/ml)
|
|
|
|
|
IGFBP6 (full length)
|
|
|
|
|
IGFBP-3 (100 tests)
|
|
|
|
|
IGFBP-2 protease
|
|
|
|
|
IGFBP-1,(PP12),MABANTI-
|
|
|
|
|
IGFBP-3, Human, Recombinant
|
|
|
|
|
IGFBP-3 Immunoassay
|
|
|
|
|
IGF BP-3 Elisa
|
|
|
|
|
IGFBP-3 (12 x 8 tests)
|
|
|
|
|
IGFBP-5 ( Insulin-like Growth Factor Binding Protein 5、IBP5)
|
|
|
|
|
IGFBP-RP1, ANTI-HUMAN
|
|
|
|
|
IGFBP-3 (N109D)
|
|
|
|
|
IGFBP-1, ANTI-MOUSE
|
|
|
|
|
IGFBP-2, ANTI-MOUSE
|
|
|
|
|
IGFBP-6 HUMAN
|
|
|
|
|
IGFBP-5 MOUSE
|
|
|
|
|
IGFBP-4, ANTI-RAT
|
|
|
|
|
IFN-w Kit
|
|
|
|
|
ig Endothelin-3: 1-41, amide, rat
|
|
|
|
|
Ige(NhsAdsorbed)
|
|
|
|
IgE octapeptide (497-504)
|
90274-65-0
|
C41H63N11O10
|
|
|
IGEPAL(R) DM-970
|
9014-93-1
|
(C2H4O)nC24H42OC15H24O
|
|
IGEPAL(R) CO-890
|
|
C95H184O41
|
|
IGEPAL(R) CO-720
|
|
C39H72O13
|
|
|
IGEPAL CO-880 (50G)
|
|
|
|
IGEPAL CA-210
|
68987-90-6
|
C16H26O2
|
|
|
IGEPONAP-78
|
|
|
|
|
IGEPON
|
|
|
|
igercine
|
92891-56-0
|
C39H70N14O12
|
|
|
IGF-1,HCG,HGH
|
|
|
|
|
IgG2
|
|
|
|
|
IgG3
|
|
|
|
|
IGF-I (1-3)
|
|
|
|
IGF-I (24-41)
|
135861-49-3
|
C88H133N27O28
|
|
|
IgG4
|
|
|
|
|
IgE Quantitative
|
|
|
|
|
IGF-I, ANTI-RAT
|
|
|
|
|
IGF-I, ANTI-BARRAMUNDI (FISH)
|
|
|
|
|
IGF-I, ANTI-SALMON/TROUT
|
|
|
|
|
IGF-I BARRAMUNDI
|
|
|
|
|
IGF-I direct (Rat, Mouse) (12 x 8 tests)
|
|
|
|
|
IGF-I direct (Rat, Mouse)(Standard Range: 217 - 2.200 pg/l)
|
|
|
|
|
IGF-I (extraction)(Standard Range: 0,5 - 50 ng/ml)
|
|
|
|
|
IGF-I (extraction) (96 tests)
|
|
|
|
|
IGF-IEC, (AA 104-110), ANTI-HUMAN
|
|
|
|
|
IGF-IEA, (AA 92-105), ANTI-HUMAN
|
|
|
|
|
IGF-IE, (AA 71-86), ANTI-HUMAN
|
|
|
|
|
IGF-IEB, (AA 104-123), ANTI-HUMAN
|
|
|
|
Ifosfamide-d4
|
1189701-13-0
|
C7H15Cl2N2O2P
|
|
|
Ifosfamide mustard
|
|
|
|
|
IFOSFAMIDE EPI(CRM STANDARD)
|
|
|
|
|
IGF-I + FITC（ Insulin-like Growth Factor-I ）
|
|
|
|
Ifosfamide
|
3778-73-2
|
C7H15Cl2N2O2P
|
|
|
Ifosfamide for Injection
|
|
|
|
|
Ifosfamide Cyclophosphamide BP/EP
|
|
|
|
|
Ifosfamide cyclophosphamide
|
|
|
|
|
IFOSFAMIDE IMPURITY A3-[(2-CHLOROETHYL)AMINO]PROPYL DIHYDROGEN PHOSPHATE EPI(CRM STANDARD)
|
|
|
|
|
IFOSFAMIDE IMPURITY E3-CHLORO-N-(2-CHLOROETHYL)PROPAN-1-AMINE EPI(CRM STANDARD)
|
|
|
|
Ifosfamide impurity A
|
22608-58-8
|
C5H13ClNO4P
|
|
IFOSFAMIDE
|
84711-20-6
|
C7H15Cl2N2O2P
|
|
|
IFOSFAMIDE IMPURITY F(RS)-2-CHLORO-3-(2-CHLOROETHYL)-1,3,2-OXAZAPHOSPHINANE 2-OXIDE STORE LONG TERM AT +4°C COOL PACK EPI(CRM STANDARD)
|
|
|
|
|
IFOSFAMIDE REFERENCE SPECTRUM EPI(CRM STANDARD)
|
|
|
|
|
IFOSFAMIDE IMPURITY BBIS[3-[(2-CHLOROETHYL)AMINO]PROPYL]DIHYDROGEN DIPHOSPHATE EPI(CRM STANDARD)
|
|
|
|
|
IGF-I, HUMAN, C-TERMINAL PEPTIDE (33-40)
|
|
|
|
|
IGF-IIE, (AA 138-156), ANTI-HUMAN
|
|
|
|
IGF-II (33-40)
|
103244-41-3
|
C38H74N20O12
|
|
|
IGF-IIE, (AA 89-101), ANTI-HUMAN
|
|
|
|
|
IGF-IIE, (AA 77-88), ANTI-HUMAN
|
|
|
|
|
IGF-II Polyclonal Antibody
|
|
|
|
|
IGF-I (Insulin-like Growth Factor-I) direct (12 x 8 tests)
|
|
|
|
|
IGF-II(full length)
|
|
|
|
|
IGF-II（ Insulin-like Growth Factor-II ）
|
|
|
|
|
IGF-I（ Insulin-like Growth Factor-I ）
|
|
|
|
|
IGF-1, Human, Recombinant, E.coli
|
|
|
|
|
IGF 1 (human), (Insuline like Growth Factor)
|
|
|
|
|
IGF-I, MOUSE
|
|
|
|
|
IGF-I Polyclonal Antibody
|
|
|
|
|
IGF-I, Recomb. Purified
|
|
|
|
|
IgG2a
|
|
|
|
|
IGF-I (Somatomedin-C) direct(Standard Range: 0,8 - 70 ng/ml)
|
|
|
|
|
IGF-I (Somatomedin-C) direct (96 tests)
|
|
|
|
|
IgG A
|
|
|
|
|
IgE strip
|
|
|
|
|
IgG2a (AP)
|
|
|
|
|
IgG2a (Biotin)
|
|
|
|
|
IgG2a, Clone: LO-MG-2a9, Mab anti-Mouse
|
|
|
|
|
IgG2a, Clone: LO-MG-2a9, Mab anti-Mouse, HRP
|
|
|
|
|
IgE total (12 x 8 tests)
|
|
|
|
|
IGG-AFFINITY GEL (A)
|
|
|
|
|
IgG2a-FITC Isotype Control from murine myeloma
|
|
|
|
|
IgG2a Isotype Control from murine myeloma
|
|
|
|
|
IgG B
|
|
|
|
|
IgG2b
|
|
|
|
|
Igg2AKappa,Mouse
|
|
|
|
|
IgG2b (AP)
|
|
|